Literature DB >> 10967022

Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules.

T Fehr1, C López-Macías, B Odermatt, R M Torres, D B Schubart, T L O'Keefe, P Matthias, H Hengartner, R M Zinkernagel.   

Abstract

This study attempted to evaluate and compare the role of various B cell-specific markers for anti-viral immune responses in mouse strains lacking molecules belonging to the B cell receptor (BCR) complex (IgM, Ig alpha and C(kappa)), the co-stimulatory molecules (CD19 and CD22), the protein kinases [Bruton's tyrosine kinase (Btk)] or the transcription factors (OBF-1). These mice were tested in two model infections [vesicular stomatitis virus (VSV) and lymphocytic choriomeningitis virus (LCMV)] using T cell-independent (TI) or T cell-dependent (TD) antigens. All mice controlled an LCMV infection indicating that cytotoxic T cell functions were within normal ranges. In contrast, OBF-1(-/-) mice were partially protected and mb-1(delta c/delta c) mice not at all protected against VSV infection, a virus that is controlled virtually exclusively by neutralizing antibodies. Susceptibility to VSV infection was correlated with structural defects in the spleen: absence of mature B cells and follicles with marginal zone macrophages and absence of germinal centers with follicular dendritic cells correlated with lack or substantial reduction of protective IgM and IgG responses respectively. The lack of kappa light chain did not affect the neutralizing response, indicating that it could easily be replaced by the lambda chain. Absence of the co-stimulatory molecules CD19 and CD22 or of the signaling molecule Btk had modulating effects, but did not increase susceptibility to VSV or LCMV. Our findings suggest that there are crucial molecules for B cell activation at the beginning (BCR complex) and the end (transcription) of the signaling cascade, whereas fine-tuning factors modulating the response in between exhibit considerable functional overlap.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967022     DOI: 10.1093/intimm/12.9.1275

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment.

Authors:  Tatjana Samardzic; Dragan Marinkovic; Peter J Nielsen; Lars Nitschke; Thomas Wirth
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

2.  Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells.

Authors:  H C Probst; K Tschannen; B Odermatt; R Schwendener; R M Zinkernagel; M Van Den Broek
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

3.  CD22 is required for protection against West Nile virus Infection.

Authors:  Daphne Y Ma; Mehul S Suthar; Shinji Kasahara; Michael Gale; Edward A Clark
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

4.  The price of the CD27-CD70 costimulatory axis: you can't have it all.

Authors:  Martijn A Nolte; René A W van Lier
Journal:  J Exp Med       Date:  2006-10-23       Impact factor: 14.307

5.  Differential requirement for OBF-1 during antibody-secreting cell differentiation.

Authors:  Lynn M Corcoran; Jhagvaral Hasbold; Wendy Dietrich; Edwin Hawkins; Axel Kallies; Stephen L Nutt; David M Tarlinton; Patrick Matthias; Philip D Hodgkin
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

6.  Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.

Authors:  Lynn Corcoran; Dianne Emslie; Tobias Kratina; Wei Shi; Susanne Hirsch; Nadine Taubenheim; Stephane Chevrier
Journal:  Front Immunol       Date:  2014-03-20       Impact factor: 7.561

Review 7.  CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity.

Authors:  Edward A Clark; Natalia V Giltiay
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

Review 8.  Neutralizing antiviral antibody responses.

Authors:  R M Zinkernagel; A LaMarre; A Ciurea; L Hunziker; A F Ochsenbein; K D McCoy; T Fehr; M F Bachmann; U Kalinke; H Hengartner
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

9.  B cell response is required for granuloma formation in the early infection of Schistosoma japonicum.

Authors:  Fang Ji; Zhanjie Liu; Jianping Cao; Na Li; Zhijian Liu; Jinxin Zuo; Yan Chen; Xinzhi Wang; Jian Sun
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.